Merck's RotaTeq Safety Data Is Reassuring, FDA Vaccine Committee Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Vaccines & Related Biological Products Advisory Committee votes unanimously that Merck's data indicate the rotavirus vaccine is safe.
You may also be interested in...
Merck’s RotaTeq Post-Marketing Study Will Center On Safety
The study will enroll 44,000 infants immunized with the rotavirus vaccine, which was approved Feb. 3.
Merck’s RotaTeq Post-Marketing Study Will Center On Safety
The study will enroll 44,000 infants immunized with the rotavirus vaccine, which was approved Feb. 3.
Merck Rotavirus Vaccine Has Low Risk Of Intussusception, FDA Review Says
Discrepancies in reports of follow-up time prevent the agency from reaching a conclusion on RotaTeq’s efficacy.